[1] Y Xu, L Wang, J He et al. Prevalence and Control of Diabetes in Chinese Adults [J]. JAMA,2013,310(9):948-958.
[2] Lea J, Pnicholas SB. Diabetes mellitus and hypertension: Key risk factors for kidney disease[J].J Natl Med Assoc,2008, 94(Suppl 8):7-15.
[3] Dalla VestraM, MasieroA, RoiterAM, et al.Is podocyte injury relevant in diabetic nephro-pathy? Studies in patients with type 2 diabetes[J].Diabetes, 2003,52(4):1031-1035.
[4] 杨倩,梁伟,丁国华.足细胞损伤与糖尿病肾病[J].中国医学前沿杂志,2012, 4(9):10-13.
[5] Ziyadeh F N,Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glo-merulopathy[J].Curr Diabetes Rec,2008,4(1):39- 45.
[6] 高彦彬,赵慧玲,周晖,等.糖肾宁治疗气阴两虚、络脉瘀滞型早期糖尿病肾病临床研究[J].中华中医药杂志,2006,21(7):409- 411.
[7] 徐丽华,刘春雷,常玉梅,等.双标准曲线相对定量PCR试验原理与方法[J].生物技术通报,2011,(1):70-75.
[8] 杨亦彬, 张翥, 苏克亮, 等. 链脲佐菌素诱导大鼠糖尿病肾病模型的方法学探讨[J]. 华西医学, 2005,(2): 299-300.
[9] 刘晓, 高媛媛, 鲁茜,等. 银杏叶提取物、卡托普利和缬沙坦对大鼠糖尿病肾病保护作用的比较[J]. 中药材, 2008,(1): 97-100.
[10] 李秋月,李六生,李桂霞,等.坎地沙坦对糖尿病肾病大鼠足细胞Nephrin、Podocin和CD2AP表达的影响[J].华中科技大学学报(医学版),2012,41(3):310-313.
[11] 黄平,王雁秋.绞股蓝总皂苷对糖尿病肾病大鼠足细胞损伤的影响及机制[J].中华中医药杂志,2012,27(3):723-726.
[12] M. Kestila, U. Lenkkeri and M. Mannikko, et al., Positionally cloned gene for a novel glomerular protein—nephrin—is mutated in congenital nephrotic syndrome [J]. Molecular Cell,1998, 1(4): 575-582.
[13] 石绮屏. Nephrin基因表达的改变与糖尿病肾病[J]. 国外医学(内分泌学分册),2004,(1): 5-27.
[14] F. Bonnet, M.E. Cooper, H. Kawachi, et al., Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension[J]. Diabetologia, 2001,44(7): 874- 877.
[15] 孙桂芝,孙艳艳,方敬爱.糖尿病肾病足细胞损伤的研究进展[J].中国中西医结合肾病杂志,2008,9(2):177-178.
[16] LIY, KANG Y S, DAIC, etal. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria[J].Am J Pathol,2008,172(2):299-308.
[17] ZhangC,HuJJ,XiaM,et al. Protection of Podocytes from hy Perhomocysteinemia-induced injury by deletion of the gP91Phox gene[J].Free Radic Biol Med,2010,48:1109-1117.
[18] H.Y. Dai, M. Zheng, R.N. Tang, et al. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy[J].American Journal of the Medical Sciences,2011,341(3):207-214.
[1]刘孝琴 王云枫 李雅楠.参芪地黄汤加味配合门冬胰岛素对早期2型糖尿病肾病
负氮平衡的影响[J].环球中医药,2013,6(05):366.
[2]王涵 周强 仝小林.仝小林治疗糖尿病并发症应用黄芪经验[J].环球中医药,2013,6(04):272.
[3]李光超 车念聪 耿建国等.加味消渴康对糖尿病肾病大鼠肝组织细胞外基质相关
调节因子表达的影响[J].环球中医药,2014,7(02):88.
LI Guang chao,CHE Nian cong,GENG Jian guo,et al.The effects of JiaweiXiaokekang on the expressions of factors regulating the hepatic extracellular matrix in DN rats[J].,2014,7(03):88.
[4]郑洪光,李秀兰,石燕萍,等.糖尿病肾病130例中医证型分类研究[J].环球中医药,2012,5(10):783.
[5]齐铮,赵进喜,王硕仁,等.糖尿病肾病中医证候分布规律的文献研究[J].环球中医药,2012,5(12):914.
QI Zheng,ZHAO Jin-xi,WANG Shuo-ren,et al.Distribution regules on syndrone of diabetic nephropathy[J].,2012,5(03):914.
[6]周盛楠 高彦彬 李娇阳等.通心络对早期糖尿病肾病大鼠肾功能及肾组织NO/eNOS表达的影响[J].环球中医药,2014,7(11):821.
ZHOU Sheng-nan,GAO Yan-bin,LI Jiao-yang,et al.Effects of Tong Xinluo on renal function and NO/eNOS expression in kidney in DN rats[J].,2014,7(03):821.
[7]熊燕.余江毅教授治疗糖尿病肾病经验[J].环球中医药,2015,8(04):474.[doi:10.3969/j.issn.1674-1749.2015.04.028]
[8]邹大威,高彦彬,刘迎新,等.糖肾宁对自发性2型糖尿病KKAy小鼠肾组织MMP9、TIMP1表达的影响[J].环球中医药,2015,8(11):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
ZOU Da wei,GAO Yan bin,LIU Ying xin,et al.Effects of Tangshenning on MMP9、TIMP1 expression of renal tissue in type 2 diabetic KKay mice[J].,2015,8(03):1324.[doi:10.3969/j.issn.1674-1749.2015.11.013]
[9]申子龙,赵进喜,王颖辉,等.基于因子分析的早期糖尿病肾病证候要素研究[J].环球中医药,2016,9(02):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]
SHEN Zi-long,ZHAO Jin-xi,WANG Ying-hui,et al.Study on the syndrome characteristics of early diabetic nephropathy based on the factor analysis[J].,2016,9(03):129.[doi:10.3969/j.issn.1674-1749.2016.02.001]
[10]贾冕,赵进喜,皇甫伟.基于中医证候学的糖尿病肾病患者肾小球滤过率评估方法的探索[J].环球中医药,2016,9(03):275.[doi:10.3969/j.issn.1674-1749.2016.03.006]
JIA Mian,ZHAO Jin xi,HUANG Fu Wei..Exploration of GFR evaluation method in patients with diabetic nephropathy based on the theory of TCM syndrome[J].,2016,9(03):275.[doi:10.3969/j.issn.1674-1749.2016.03.006]